Hot Stocks: Brokerages view on M&M Finance, Mankind Pharma, HPCL, Indigo and Titan Company

Brokerage firm Morgan Stanley maintained an equal-weight rating on M&M Finance, Macquarie had an outperform rating on Mankind Pharma, Jefferies retained an underperform rating on HPCL, Morgan Stanley had a buy call on Indigo and HSBC maintained a buy on Titan Company.

We have collated a list of recommendations from top brokerage firms from ETNow and other sources:

Morgan Stanley on M&M Finance: Equal-Weight| Target Rs 300
Morgan Stanley maintained an equal-weight rating on M&M Finance with a target price of Rs 300. Disbursements and collections remained strong in July. Collection efficiency in July was also marginally better.

Macquarie on Mankind Pharma: Outperform| Target Rs 1450
Macquarie maintained an outperform rating on Mankind Pharma with a target price of Rs 1450. The company reported another all-around beat.

The growth in revenues drove the EBITDA beat. The company reported better-than-expected gross margins and operating leverage.

Jefferies on HPCL: Underperform| Target Rs 225

Jefferies maintained an underperform rating on HPCL but raised the target price to Rs 225 from Rs 205 earlier.

Q1 earnings remained strong, but the best is behind. The global investment bank believes earnings have peaked, with a narrowed discount on Russian crude offsetting recent strength in refining margins and rising oil prices hurting marketing.Preferential allotment to the government could lead to further capital allocation concerns.

Morgan Stanley on InterGlobe Aviation: Buy| Target Rs 2600

Morgan Stanley maintained a buy rating on InterGlobe Aviation but slashed the target price to Rs 2600 from Rs 2730 earlier.

The results were in-line, but the company has guided for a weak Q2. Now, all eyes are on Q3 – Cricket World Cup.

Indigo is likely to make a loss in Q2, but the long-term fundamentals are intact. The global investment bank slashed FY25/FY26 PBT by 9%/7% primarily on lower yield assumptions.

HSBC on Titan Company: Buy| Target Rs 3580

HSBC maintained a buy rating on Titan Company with a target price of Rs 3580. The margin miss for Q1 is tactical. Other divisions delivered double-digit growth.

The scaling up of the international jewellery division is on track. The global investment bank retained a buy rating on Titan given its winning jewellery business and strong growth outlook.

(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)